Add-on Acquisition • Life Science

Frontier Biosolutions Acquires Coriolis Pharma

On October 16, 2023, Frontier Biosolutions acquired life science company Coriolis Pharma

Acquisition Context

This is Frontier Biosolutions’ 1st transaction in the Life Science sector.
This is Frontier Biosolutions’ 1st transaction in Germany.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	October 16, 2023
Target	Coriolis Pharma
Sector	Life Science
Buyer(s)	Frontier Biosolutions
Deal Type	Add-on Acquisition

Target Company

Coriolis Pharma

Martinsried, Germany

Coriolis Pharma provides formulation research and development, analytical services and non-GMP manufacturing of innovative high-value biologics and cell and gene therapy products. Coriolis Pharma is based in Martinsried, Germany.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Frontier Biosolutions

New York, New York, United States

Category	Company
Sector	Life Science

DESCRIPTION

Frontier Biosolutions is a global pharma services platform. Frontier Biosolutions is based in New York.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Germany	1 of 1
Year: 2023	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Germany M&A - 2023 M&A